| Primary |
| Drug Use For Unknown Indication |
21.7% |
| Product Used For Unknown Indication |
15.7% |
| Pain |
15.5% |
| Back Pain |
9.0% |
| Analgesic Therapy |
6.7% |
| Gastritis |
3.7% |
| Intervertebral Disc Protrusion |
3.7% |
| Pain Management |
3.3% |
| Pain In Extremity |
3.1% |
| Arthralgia |
2.7% |
| Hypertension |
2.5% |
| Postoperative Analgesia |
2.0% |
| Analgesia |
1.8% |
| Diabetes Mellitus |
1.4% |
| Procedural Pain |
1.4% |
| Depression |
1.2% |
| Herpes Zoster |
1.2% |
| Paraesthesia |
1.2% |
| Gastrointestinal Disorder Therapy |
1.0% |
| Prophylaxis |
1.0% |
|
| Vomiting |
16.8% |
| Drug Abuser |
6.5% |
| Shock |
6.5% |
| Muscular Weakness |
5.6% |
| Death |
4.7% |
| Pain |
4.7% |
| Rash |
4.7% |
| Suicide Attempt |
4.7% |
| Syncope |
4.7% |
| Unresponsive To Stimuli |
4.7% |
| Weight Decreased |
4.7% |
| Convulsion |
3.7% |
| Delirium |
3.7% |
| Dizziness |
3.7% |
| Low Density Lipoprotein Increased |
3.7% |
| Tachycardia |
3.7% |
| Tremor |
3.7% |
| Withdrawal Syndrome |
3.7% |
| Fall |
2.8% |
| Haemorrhoids |
2.8% |
|
| Secondary |
| Pain |
14.0% |
| Product Used For Unknown Indication |
12.7% |
| Drug Use For Unknown Indication |
11.0% |
| Back Pain |
10.5% |
| Pain Management |
7.5% |
| Intervertebral Disc Protrusion |
7.3% |
| Hypertension |
4.3% |
| Pain In Extremity |
4.1% |
| Arthralgia |
3.9% |
| Prophylaxis |
3.4% |
| Depression |
3.2% |
| Analgesic Therapy |
3.0% |
| Osteoarthritis |
2.4% |
| Rheumatoid Arthritis |
2.4% |
| Arthritis |
2.2% |
| Intervertebral Disc Disorder |
2.2% |
| Bipolar Disorder |
1.7% |
| Crohn's Disease |
1.7% |
| Hypersensitivity |
1.3% |
| Migraine |
1.3% |
|
| Withdrawal Syndrome |
18.8% |
| Drug Hypersensitivity |
11.5% |
| Vomiting |
11.5% |
| Pain |
6.3% |
| Drug Ineffective |
4.2% |
| Low Density Lipoprotein Increased |
4.2% |
| Muscular Weakness |
4.2% |
| Polychondritis |
4.2% |
| Rhabdomyolysis |
4.2% |
| Vision Blurred |
4.2% |
| Wrong Technique In Drug Usage Process |
4.2% |
| Fall |
3.1% |
| Neutropenia |
3.1% |
| Serotonin Syndrome |
3.1% |
| Somnolence |
3.1% |
| Constipation |
2.1% |
| Dizziness |
2.1% |
| Faecaloma |
2.1% |
| Haemorrhoids |
2.1% |
| Incorrect Drug Administration Duration |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.9% |
| Drug Use For Unknown Indication |
11.6% |
| Pain |
11.4% |
| Rheumatoid Arthritis |
10.6% |
| Hypertension |
5.7% |
| Prophylaxis |
4.2% |
| Osteoporosis |
3.2% |
| Depression |
2.9% |
| Diabetes Mellitus |
2.7% |
| Back Pain |
2.6% |
| Constipation |
2.2% |
| Insomnia |
2.1% |
| Abdominal Pain |
2.0% |
| Multiple Myeloma |
1.9% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Arthritis |
1.8% |
| Anxiety |
1.8% |
| Decreased Appetite |
1.7% |
| Asthma |
1.5% |
| Arthralgia |
1.3% |
|
| Weight Decreased |
16.8% |
| Vomiting |
11.9% |
| Weight Increased |
10.6% |
| Pneumonia |
6.8% |
| Myocardial Infarction |
5.4% |
| Urinary Tract Infection |
4.7% |
| Pulmonary Embolism |
4.5% |
| Pain |
4.0% |
| Septic Shock |
3.8% |
| Nausea |
3.4% |
| Drug Ineffective |
3.2% |
| Thrombocytopenia |
3.2% |
| Pain In Extremity |
3.1% |
| Febrile Neutropenia |
2.9% |
| Type 2 Diabetes Mellitus |
2.9% |
| Deep Vein Thrombosis |
2.7% |
| Death |
2.5% |
| Dyspnoea |
2.5% |
| Syncope |
2.5% |
| Transient Ischaemic Attack |
2.5% |
|
| Interacting |
|
|
